SPIA
JUNO

Steward Partners Investment Advisory’s Juno Therapeutics, Inc. JUNO Stock Holding History

Steward Partners Investment Advisory’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2,000
Closed -$91K – 2415
2017
Q4 		$91K Buy
2,000
+820
+69% +$40.9K 0.01% 655
2017
Q3 		$52K Hold
1,180
– – 0.01% 686
2017
Q2 		$35K Hold
1,180
– – ﹤0.01% 722
2017
Q1 		$26K Buy
1,180
+1,000
+556% +$21.4K ﹤0.01% 691
2016
Q4 		$3K Buy
+180
New +$4.4K ﹤0.01% 737

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Steward Partners Investment Advisory's JUNO Position: Q1 2018 in Review

Steward Partners Investment Advisory sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 2,000 shares — an estimated $91K sold.

Steward Partners Investment Advisory first reported a position in JUNO in Q4 2016 and held it in 5 quarters. The position peaked at $91K in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Steward Partners Investment Advisory reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 2,000 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $91K.
  • Steward Partners Investment Advisory first reported a position in Juno Therapeutics, Inc. in Q4 2016 and held it in 5 quarters.
  • Steward Partners Investment Advisory's Juno Therapeutics, Inc. position peaked at $91K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2018, filed 20 Apr 2018.